Danish Drugtest & Health Services ApS
CVR 44923076 · Private limited company (ApS) · Active · Medium risk
Danish Drugtest & Health Services ApS is a Private limited company (ApS), founded on , based in Esbjerg. The company is registered in the industry anden teknisk rådgivning. Our model estimates a bankruptcy risk of 1.4% over the next 12 months, which is 1.0 times the average for Danish companies. 2 annual reports have been published. The latest annual report (30 Jun 2026) shows equity of DKK 332k and a net result of DKK 125k. CEO: Else Marie Terpager.
Bankruptcy risk for Danish Drugtest & Health Services ApS
1.0 × the average (1.41%) · higher risk than 77% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 44923076
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (2 years)
- Address
- Auktionsgade 3
6700 Esbjerg - Municipality
- Esbjerg
- Industry
- Anden teknisk rådgivning (711290)
Bankruptcies in the industry: Rådgivende ingeniørvirksomhed inden for byggeri og anlægsarbejder - Share capital
- DKK 420k
- Auditor
- PricewaterhouseCoopersStatsautoriseret Revisionspartnerselskab
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 0 of 2 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 30.1% |
| Current ratio | 124% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 1 |
| CEO's previous bankruptcies | 1 |
| Other companies at the address | 9 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2026 | 2025 |
|---|---|---|
| Gross profit | DKK 924k | DKK 193k |
| Net profit | DKK 125k | DKK -212k |
| Equity | DKK 332k | DKK 208k |
| Total assets | DKK 1.1m | DKK 321k |
| Cash | DKK 382k | DKK 14k |
| Short-term debt | DKK 773k | DKK 113k |
| Avg. employees | 1 | 1 |
Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · PricewaterhouseCoopersStatsautoriseret Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jul 2025 – 30 Jun 2026 | 101 | ||
| 1 Jul 2024 – 30 Jun 2025 | 113 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Else Marie Terpager | Current | |
| CEO | Max Terpager | ||
| Board | Henrik Gliese | Current | |
| Board | Bent Würsching | Current | |
| Board | Nis Peter Rasmussen | Current | |
| Owner (15%) | HENRIK GLIESE HOLDING ApS | Current | |
| Owner (15%) | NIS RASMUSSEN HOLDING ApS | Current | |
| Owner (15%) | Kit Sonja Stryhn | Current | |
| Owner (33%) | HOLDINGSELSKABET K90 ApS | Current | |
| Owner (10%) | WD-Care ApS | Current | |
| Owner (50%) | HOLDINGSELSKABET K90 ApS | ||
| Owner (15%) | WD-Care ApS | ||
| Auditor | PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB | ||
| Founder | HOLDINGSELSKABET K90 ApS | Current | |
| Founder | HENRIK GLIESE HOLDING ApS | Current | |
| Founder | NIS RASMUSSEN HOLDING ApS | Current | |
| Founder | WD-Care ApS | Current |
The CEOs' other companies
Else Marie Terpager – 7 other companies, of which 1 bankrupt
- BioBottle ApS Bankrupt 8 May 2023
- Conest ApS Active
- DENTEX OVERSØISK A/S Fusioneret
- H17 A/S Fusioneret
- Holdingselskabet E21 ApS Active
- L90 A/S Opløst
- TERPAGER DENTAL A/S Fusioneret
Max Terpager – 15 other companies
- A2 DENTAL ApS Opløst
- DENTEX OVERSØISK A/S Fusioneret
- DKM DENTAL ApS Opløst
- ELSE MARIE OG MAX TERPAGER INVEST ApS Fusioneret
- EMT HOLDING, ESBJERG ApS Fusioneret
- H17 A/S Fusioneret
- HOLDINGSELSKABET K90 ApS Active
- L90 A/S Opløst
- METRO JF 4 ApS Active
- OSTEKLOKKEN A/S Opløst
- PharmaMénta Aps Active
- STELCO DENTAL ApS Compulsorily dissolved
- TERPAGER DENTAL A/S Fusioneret
- THP HOLDING ESBJERG ApS Active
- WITEX ApS Fusioneret
Address history (0 moves)
| Auktionsgade 3, 6700 Esbjerg |
Other companies at the same address
- AMO-HUSET ApS Active
- ARBEJDSMILJØEKSPERTEN A/S Active
- ARBEJDSMILJØEKSPERTEN ESBJERG ApS Active
- ConArk ApS Opløst
- Conest ApS Active
- HJEM-IS EUROPA A/S Fusioneret
- HJEM-IS PRODUKTION A/S Fusioneret
- KTP Byggeledelse ApS Active
- L90 A/S Opløst
Similar companies in Esbjerg
- Blue Water Tec A/S Esbjerg
- Stausholm ApS Esbjerg V
- Nicon Energy BESS Ringsted 1 ApS Esbjerg Ø
- NR-Consulting ApS Esbjerg
- GreenEnergyConsulting ApS Bramming
- ICOM Energy Services ApS Esbjerg
- Societate ApS Bramming
- Greenfuels Esbjerg ApS Esbjerg Ø
- Bachup ApS Esbjerg
- Kongstein Danmark A/S Esbjerg
- A2X A/S Esbjerg Ø
- Reccura ApS Esbjerg
Questions and answers about Danish Drugtest & Health Services ApS
Has Danish Drugtest & Health Services ApS gone bankrupt?
No, Danish Drugtest & Health Services ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Danish Drugtest & Health Services ApS?
Our model estimates a bankruptcy risk of 1.4% over the next 12 months (medium risk), which is 1.0 times the average for Danish companies.
Who is the CEO of Danish Drugtest & Health Services ApS?
Else Marie Terpager is the CEO of Danish Drugtest & Health Services ApS.
Who is the auditor of Danish Drugtest & Health Services ApS?
Danish Drugtest & Health Services ApS most recently used PricewaterhouseCoopersStatsautoriseret Revisionspartnerselskab.
When was Danish Drugtest & Health Services ApS founded?
Danish Drugtest & Health Services ApS was founded on 20 June 2024.
What is the equity of Danish Drugtest & Health Services ApS?
Equity was DKK 332k according to the annual report for the period ending 30 June 2026.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.